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In accommodating the healthcare need of patients, medical and clinical officers in any health 
centre must provide prescriptions that meet their demands. There has been an increasing debate 
on the motivational factors which describes how physicians prescribe drugs for their patients, 
more so with the increased anti-hypertensive rate in Kenya with specific focus in Kiambu 
County. While this could be as a result of brand loyalty developed by either the patients or 
physicians, little literature is available in the field of healthcare management to back-up the 
belief, more so in Kenya. To try and answer this phenomenon, the study aimed to investigate 
brand loyalty and its influence on the prescription behaviour of anti-hypertensive drugs by 
medical officers and clinical officers in Kiambu Level 5 and Ruiru Sub County Hospitals. The 
specific objective were to determine the influence of brand image, brand commitment and 
brand experience on prescription behaviour of anti-hypertensive drugs. Theory of brand equity 
and theory of planned behaviour contributed to the study. The study adopted a descriptive 
research design with a target population of 21 medical officers and 34 clinical officers in the 
two hospitals combined, totalling to 55 respondents. Census survey was carried out on the 55 
respondents to make the sample size of the study. As such, the sample size of the study was 55 
respondents. The study relied on primary data which were gathered using questionnaire as the 
primary data collection instrument. Pilot testing was done using three respondents from 
Kiambu level 5 hospital which is not part of the target population. Data was analysed using 
quantitative methods, descriptive statistics, inferential statistics as well as use of SPSS. To 
ensure that analysis was appropriate, diagnostic tests was performed such as linearity test and 
normality test. The study findings established that of the three variables, only brand experience 
and brand image had a positive relationship with prescription behaviour of anti-hypertensive 
drugs by medical and clinical officers whereas, brand commitment had a negative relationship. 
The study recommended that hospitals need to take into consideration the influence that brand 
loyalty could be having on the prescription behaviour of their behaviours especially due to 
rising uptake of anti-hypertensive drugs in the country, especially in Kiambu.  
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OPERATIONAL DEFINITION OF TERMS 
Anti-hypertensive:  Refers to a drug used to reduce the level of high blood pressure 
(Benjamin et al., 2017). 
Brand commitment: Refers to the ability of the firm to create long term relationship with its 
clients so as to have a strong perception towards its brand (Eisingerich 
&Rubera, 2010). 
Brand experience: This is a type of experimental selling or marketing technique that 
includes a holistic set of terms or conditions created by the management 
to influence consumer’s feelings towards their brand or brand image 
(Biedenbach&Marell, 2010). 
Brand image: Refers to how consumers think of a brand. It is the perception of the 
brand in the minds of the consumers and it develops over time, after 
interaction (Moerman, 2006). 
Brand loyalty: It is the perceived degree of faithfulness that consumers have towards a 
particular brand of a product in the market (Macit, Taner, Mercanoglu 
& Mercanoglu, 2016). 
Clinical Officers:  Refers to clinicians with diploma in medicine and are not specialized in 
handling complicated medical issues such as surgery. They do primary 
care (Mutua et al., 2014). 
High blood pressure Refers to systolic blood pressure (SBP) greater than or equals to 140 
mmHg or diastolic blood pressure (DBP) greater than or equals to 90 
mmHg (Benjamin et al., 2017) 
Medical Officers: Refers to physicians with degree in medicine and are highly trained to 
handle high medical complications in the hospital such as surgery 





1.1 Background of the Study 
In accommodating the healthcare need of the patients, medical officers and clinical officers in 
any health centre must provide prescriptions that meet their demands. Even though technology 
and globalization has made it easier for consumers, mostly patients to have more knowledge 
on the available features of the medicine drugs in the market, few have managed to capitalize 
on it. And as a result, patients are mostly following and trusting the medicines prescribed to 
them by medical officers in the hospital (Hajjar,Frost, Lacy &Kotchen, 2006).  
In a competitive industry where firms’ main goal is to make profit, starting from 
pharmaceutical firms to healthcare organizations, brand is considered as the most effective and 
available strategy at hand (Vigolo & Cassia, 2015). Research and development (R&D) is 
becoming expensive for many healthcare organizations in the country. While many 
international health centres are engaging in R&D to introduce new medicines in partnership 
with pharmaceutical firms (Chen, Newell, Kou, Zhang, & Li, 2017), developing nations still 
lag behind. And as such, rely on brand to enhance their sales. 
Hypertension is a critical disease that is currently facing both developed and developing 
nations. A study by Joshi, Alim, Kengne, Jan, Maulik, Peiris and Patel (2014) in establishing 
prevalence of hypertension and associated cardiovascular risk factors in Nairobi’s urban slums 
indicated that in Africa, hypertension ranges from 25 – 35 per cent in people aged 25 years to 
64 years. Further, Meme (2017) indicated that Kiambu had 33 per cent of the total hypertensive 
cases reported in the country based on the 2012 survey. While the cases may have risen over 
the years, this figure has brought into attention the need to bridge the gap by establishing brand 
loyalty and its influence on prescription behaviour of anti-hypertensives drugs in Kiambu Level 
4 and Ruiru Sub-County Hospitals. 
1.1.1 Brand Loyalty 
According to Macit, Taner, Mercanoglu and Mercanoglu (2016), brand loyalty is perceived as 
the degree of faithfulness that consumers (physicians) have towards a particular brand of a 
product in the market and is a major indicator of long-term rate of consumption (prescription) 
level by consumers (physicians) towards that brand. As such, Vigolo and Cassia (2015) 
outlined that consumers judge brand on the basis of informational cues that they associate with 
the product; and can either be intrinsic (flavour, colour and texture) or extrinsic cues.  
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Brand loyalty is not only important in determining consumption rate, but also on the 
prescription of drugs by the clinicians (Berndt & Aitken, 2011). Brand gives consumers strong 
perception of a product after consuming it for the first time, depending on the benefits and 
values they derive from it. Like in health organizations, medical officers and clinical officers 
provide consultancy which aim at informing patients the available drugs, their side effects, 
benefits and the kinds of diseases they treat in the market (Joyce, Carrera, Goldman & Sood, 
2011). 
Magno (2013) in his study indicated that creating brand loyalty in the health sector is a process. 
First, physicians must be influenced by the previous image which may make them to ignore 
new medicine arrivals in the market. Second, physicians or organizations consider quality in 
areas that resonate well with the patients. Also, patients do not have all information pertaining 
to certain brands in the market. And as a result, rely on their medical officers and clinical 
officers to have the final say (Magno, 2013). 
Kabiraj and Shanmugan (2011) argued that attitude aspect was important as behavioural aspect 
in establishing brand loyalty. People develop rational and emotional behaviour which assist 
them to acquire perceived quality and value creation from a brand. A study by Fullerton (2003) 
cited in the work of Maheshwari, Lodorfos and Jacobsen (2014) revealed that commitment is 
essential in brand loyalty as it emphasizes on values, trust and perceived quality. Brakus et al., 
(2009) also identified brand experience as another important driver of brand loyalty which 
increases brand personality.  
In an attempt to determine the influence of brand loyalty on the prescription behaviour among 
medical officers and clinical officers on anti-hypertensive, the study adopted brand image 
(Mehralian et al., 2017), brand experience and brand commitment (Brakus et al., 2009) as 
predictor variables of the study. Several measures were developed such as I prescribe drugs 
based on the personality behind it (brand image), my attitudes and loyalty determines how I 
prescribe medicines over time (brand commitment), I prescribe drugs based on the drug 
awareness in the market (brand experience) among others as will be operationalized by the 
study. 
1.1.2 Prescription Behaviour of Physicians 
Prescription decision is a complicated phenomenon in the health sector (Sharifnia, 
Mohammadzadeh, Arzani, Salamzadeh, Abolfazli, Zali, & Khoshdel, 2018)). With growing 
number in population of patients seeking for medicine prescription from their physicians, 
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understanding the underlying behaviours of how physicians prescribe drugs is very important 
(Nair, Manchanda & Bhatia, 2010; Kenneth, Lakhawat & Chandra, 2016).Several researchers 
such as Sharifinia et al., (2018) in an survey study to understand factors affecting prescription 
behaviour of physician behaviour proposed several aspects such as physician’s experience and 
traits, health facilities, patients’ needs or expectations, drug strength and the type of diseases.  
Previous studies have indicated that individuals are rational in decision-making. The 
prescribing decision is a complex process that involve a number of factors (Godin et al., 2008). 
As a result, physicians adopt a number of strategies when making prescribing decisions. While 
behaviour of physicians may vary in many aspects, this study seeks to understand prescription 
behaviour of physicians. The study developed measures such as I consider cost of these drugs 
at the time of prescribing behaviour, I take into account drug issues such as side effects during 
prescribing behaviour, I also identify individual issues such as patient’s drug persistence during 
prescribing decision, and various forms of pharmaceutical promotions may persuade how I 
prescribe drugs to the patients. 
1.1.3 Anti-Hypertensives 
Globally, hypertension is the leading cause of deaths among young and adult population 
(WHO, 2009). Benjamin et al., (2017) in their study defined hypertension as the systolic blood 
pressure (SBP) greater than or equals to 140 mmHg or diastolic blood pressure (DBP) greater 
than or equals to 90 mmHg, or simply, taking anti-hypertensive medications. It was estimated 
to have caused 9.4 million deaths which was about 17 per cent of total deaths in 2012. In 
addition, the overall prevalence of hypertension as of 2015 was 24 per cent for men and 20 per 
cent for women aged 18 years and above, with an increase in hypertension cases of 1.13 billion 
in 2015 up from 594 million in 1975 (Benjamin et al., 2017). 
Over the years, African continent had not paid much attention to anti-hypertensive as have been 
witnessed today. According to Ataklte et al., (2014) Sub-Saharan Africa (SSA) currently has 
the highest prevalence of hypertension cases in the world at approximation of 30 per cent with 
about 54 percent reported in Soweto, South Africa. Whereas developed nations has seen 
decrease in hypertension cases, it is estimated that by the year 2025, the number of people 
taking anti-hypertensive may increase to approximately 68 per cent if the problem is not 
carefully addressed (Twagirumukizaet al., 2011). 
Being the most dominant non-communicable diseases (NCD), surveillance data shows that it 
has risen to 45 per cent in 2010 up from 35 per cent down in 2003 in Kenya. In the country, 
4 
 
the problem is mostly reported from cases of heart failure or cardiovascular complications and 
early deaths. A study by Joshi et al., (2014) on awareness and treatment indicated that 
awareness range between 6 – 47 per cent while treatment range between 9 – 31 per cent. The 
existing studies have not assessed criticallythe brand loyalty and its influenceon prescription 
behaviour of anti-hypertensive drugs by medical officers and clinical officers. Most studies 
such as Meme (2017) and Gatwiri (2017) only addressed the prevalence and factors leading to 
increase of hypertension cases. The paper therefore aimed to fill the gap. 
Further, Mutua et al., (2014) indicated that many hypertensive patients most often visit health 
centres due to health complications caused by the disease. The Ministry of Health in its survey 
2012 as cited in (Gatwiri, 2017) recorded that Kiambu County was the leading County with 
hypertension problems estimated at 126,754. From the records in the hospitals in the County, 
hypertension disease is ranked seventh and fifth in causing fatality and admission. The records 
further suggested that there were 193 admission cases of uncontrolled hypertensions which 
caused 27 deaths in 2011, and 328 cases of hospital admission which caused 40 deaths in 2012 
(Gatwiri, 2017). 
1.1.4 Kiambu Level 5 and Ruiru Sub-County Hospitals 
Kiambu Level 5 and Ruiru Sub-County hospitals are government hospitals located in Kiambu 
County with the sole purpose of serving the people of Kenya of all origin. As the previous 
studies have indicated, the county have seen increase of hypertension cases in the last decades. 
Therefore there was need for more studies to understand the behaviours of the physicians in 
these two hospitals and how they prescribe anti-hypertensive drugs. 
1.2 Research Problem 
With increased generic medicine substitution in the market, Sharad and Hassali (2011) argue 
that it reduces consumers’ expenditure on medicine. As the world changes and the level of 
integration increases at a faster rate, health organizations together with pharmaceutical firms 
are torn between how to enhance their market share and increase the perception of their brand 
and quality among their consumers. 
An area that remains largely unaddressed by the existing studies is the prescription behaviours 
among medical officers and clinical officers in the country and whether brand loyalty of 
physicians towards pharmaceutical firms play a key role in it. With the rate of anti-hypertensive 
intake increases on annual basis (Mutua et al., 2014) in the country, there is a need to 
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understand how medical officers and clinical officers prescribe these medicines to the patients; 
with special reference to generic and original drugs in the market. 
Previous studies such as Macit et al., (2016) on brand loyalty as a strategy for the competition 
with generic drugs by physicians noted that 92% of their respondents concurred that in most 
cases, doctors prescribe drugs based on their originality to patients with chronic diseases while 
Mwangagi (2010) on the effectiveness of brand perceived quality on the choice of prescriptions 
of drugs by doctors established that price is essential when it comes to prescription of medicine. 
Although there are many studies in line with brand loyalty, few studies have managed to 
address the brand loyalty and its impact on prescription of anti-hypertensive, more so in 
Kiambu, Kenya where the rate of hypertension is increasing by the day (Gatwiri, 2017). 
Therefore to bridge this gap and to understand how medical officers and clinical officers in 
Kiambu Level 5 and Ruiru Sub-County prescribe medicines to their patients, the study aimed 
to determine the brand loyalty and its influence on prescription behaviour of anti-hypertensive 
drugs by medical officers and clinical officers in Kiambu Level 5 and Ruiru Sub-County 
Hospitals. 
1.3 Research Objectives 
1.3.1 General Objective 
To determine the brand loyalty and its influence on anti-hypertensive drugs prescription 
behaviour by medical officers and clinical officers in Kiambu Level 5 and Ruiru Sub-County 
Hospital. 
1.3.2 Specific Objectives 
i. To find out brand image and its influence on anti-hypertensive drugs prescription 
behaviour by medical officers and clinical officers in Kiambu Level 5 and Ruiru Sub-
County Hospitals. 
ii. To establish brand commitment and its influence on antihypertensive drugs prescription 
behaviour by medical officers and clinical officers in Kiambu Level 5 and Ruiru Sub-
County Hospitals. 
iii. To determine brand experience and its influence on anti-hypertensive drugs 
prescription behaviour by medical officers and clinical officers in Kiambu Level 5 and 
Ruiru Sub-County Hospital. 
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1.4 Research Questions 
i. Does brand image influence on antihypertensive drugs prescription behaviour by 
medical officers and clinical officers in Kiambu Level 5 and Ruiru Sub-County 
Hospital? 
ii. To what extent does brand commitment have influence on antihypertensive drugs 
prescription behaviour by medical officers and clinical officers in Kiambu Level 5 and 
Ruiru Sub-County Hospital? 
iii. Does brand experience have influence on antihypertensive drugs prescription behaviour 
by medical officers and clinical officers in Kiambu Level 5 and Ruiru Sub-County 
Hospital? 
1.5 Scope of the Study 
The scope of the study was in Kiambu Level 4 and Ruiru Sub-County Hospital. Based on their 
hospital records, there were 34 clinical officers and 21 medical officers in the hospitals 
combined. The research design was descriptive in nature since it sought to establish brand 
loyalty and its influence on prescription behaviour of anti-hypertensive drugs by medical and 
clinical officers in Kiambu Level 5 and Ruiru Sub-County Hospital. The target population of 
the study therefore was 55 respondents. As such, the sample size of the study was 55 
respondents and were established using a census survey. Further, the study was justifiable in 
this site since Kiambu County had been recorded as the county with higher cases of 
hypertensions (Mutua et al., 2014). The study took eleven (11) months (June 2018 – April 
2019). 
1.6 Significance of the Study 
The findings of the study may be useful in providing a clear picture of how medical officers 
and clinical officers prescribe anti-hypertensive drugs in the hospitals and whether brand 
loyalty play a critical role in their behaviour. 
 The pharmaceutical firms and other medicine suppliers may find the findings of the study 
useful. Also, findings of this study may address the issues relating to increased hypertension 
cases in the county which may be beneficial to the ministry of health.  
To the researchers and students, the study may be useful in bringing forth the debate on the 
influence of brand loyalty on prescription behaviour of medical and clinical officers and also 
providing additional literature on the topic so as to broaden the area of the study and in the 
health management field. 
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The study was also significant in contributing to the development of brand loyalty theory and 
empirical review through establishing various aspects of brand loyalty such as image, 
commitment and experience in describing how they influence prescription behaviour of doctors 






This area covered theories that will contribute to the study, empirical review where knowledge 
gaps were identified, conceptual framework explaining the relationship between brand loyalty 
and prescription of anti-hypertensive by medical officers and clinical officers as well as 
operationalization of variables. 
2.2 Theoretical Review 
2.2.1 Brand Equity Model 
Keller (1993) developed brand equity model to explain the concept of consumer (physician) 
behaviour and how they perceive brands in the market. The model established that for 
organizations (pharmaceutical) that want to stand out in this competitive market environment, 
they must first shape-up how their consumers (physicians) think and feel about their brands, 
and this must be created in their minds (Keller, 2001). Depending on how pharmacists do it, 
ensuring that your physicians’ mind is occupied by your brand is one step that could give the 
firm a competitive edge in the market. 
While organizations aim to create sustainable brand in the market, having the right type of 
experience around brand is very vital (Aaker, 2009), since it ensures that pharmacist’s 
physicians have specific and positive feelings about the brand, their belief towards the product 
and perceptions must also be positive (Keller, 2003). A study by Yoo, Donthu and Lee (2000) 
on examinations of selected marketing mix elements and brand equity established that 
perceived quality of brand by consumers (physicians) is essential in creating brand loyalty. 
According to Keller, Parameswaran and Jacob (2011), strong brands attract physicians to 
increase their prescription rate in the market. Based on the model developed by Keller (1993), 
there are four major steps in creating sustainable brand in the organization. First is the brand 
salience which aims at creating brand awareness so as physicians can recognize it with positive 
perceptions. Second in the model is the meaning of the brand or its image which is aimed at 
performance through meeting physicians’ needs; by ensuring reliability, durability and 
efficiency. 
Third is the brand response which aims to develop the extent of perception and feelings that 
individuals have towards the brand. Physicians’ perception of a brand is based on quality, 
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credibility and superiority (Pappu, Quester & Cooksey, 2005). Lastly, there is resonance on top 
of the model which aim to provide the level of connection that physicians have with the brand. 
Thus, this is the major breaking point that organizations must achieve so as to achieve their 
brand loyalty in the market (Kapferer, 2008). 
NathSanyal and Datta (2011) in their study showed that perceived quality of branded generics 
significantly, but indirectly, affects brand equity through the mediating variables of intrinsic 
cues and extrinsic cues. Connecting this theory to the study, it attempts to demonstrate how 
companies create strong brand which results to brand loyalty in the organization. Be it generic 
or original medicine, physicians’ level of understanding, experience and awareness with these 
medicines play key role in how they prescribe anti-hypertensive drugs in the hospital, thus the 
study seeks to identify its influence. 
2.2.2 Theory of Planned Behaviour 
The theory of planned behaviour (TPB) was developed by Icek Ajzen in 1985 to expand on the 
work of Theory of Planned Action (TPA) which emphasizes on individual’s intention to engage 
in a certain behaviour at a given time and space. The theory emphasizes on the behavioural 
intent of a person. Godin et al., (2008) in their meta-analysis study demonstrated high ability 
to predict physicians’ behaviour within the context of health care. The theory test the ability of 
attitude, personal norm and perceived behavioural control (PBC) to predict behavioural 
intentions and prescribing behaviour of physicians. 
Attitudes describes the degree of like or dislike for something which in some instances, may 
affect tendency or behaviour of a physician to act in certain ways (George, 2004). This could 
explain the extent to which a physician has a favourable or unfavourable attitude towards 
marketing drug promotions done by pharmaceutical companies which in some cases may 
influence their prescribing decisions (Ajzen, 1991). Another important aspect of TPB is the 
influence of subjective norm associated with expectation (pressure) to perform according to a 
given group of individuals or others (Conner, Norman & Bell, 2002). 
To the physicians, this can be done by social pressure resulting from patient or pharmaceutical 
firms such as patient’s demands for drugs, their expectations, pharmacist expert power as well 
as pharmacist-physician collaboration (Montano & Kazprzyk, 2015). Perceived behavioural 
control (PBC) is a function of conduct and it reflects knowledge (drug/product knowledge). 
Most factors associated with PBC are drug characteristics or issues, costs or habit persistence 
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of physicians and their responsiveness to the marketing efforts by the pharmaceutical firms 
(Oreg & Katz-Gerro, 2006). 
This theory therefore is very important to the study as it highlights various factors that influence 
prescribing behaviour of physicians and their perceptions towards marketing promotions done 
by pharmaceutical firms (Albarracin, Johnson, Fishbein & Muellerleile, 2001). The theory 
therefore relates to the study as it emphasizes on other aspects such as attitudes and expectation 
of physicians towards prescribing decision making (Norman, Conner & Bell, 1999). The theory 
therefore hypotheses the influence of brand image, brand commitment and brand experience 
on prescribing decision of behaviour of physicians in the hospital. 
2.3 Empirical Review 
The section discusses the existing studies on brand image, brand experience, brand 
commitment and how they relate to prescription behaviour of physicians. 
2.3.1 Brand Image and Prescription Behaviour 
According to Moerman (2006), the response of patients to treatment is a comprehensive 
psychological and physiological effect. This is due to the fact that treatment covers a broad 
spectrum from drug brand image, dosage forms, colour, injection volume as well as the 
behaviour of the patients. Brand image is the perception of the brand in the minds of the 
consumers and it develops over time. It normally happens after consumers’ interactions with 
brand. The success of healthcare organizations depends on how effective their medical officers 
prescribe medicines for their patients so as to meet their needs (Moerman, 2006). However, 
this study did not demonstrate how brand image can significantly influence the prescription 
behaviour among medical doctors and physicians towards anti-hypertensive drugs. 
Li et al., (2017) did a study on drug brand response and its impact on compliance and efficacy 
in depression patients. The drug image was based on the domestic brand and the imported 
brand. A survey of 459 outpatients with mild-to-moderate depression was taken and the safety 
and efficacy were evaluated both before and after the drug switch. The findings of the study 
revealed that the medication compliance of the imported brand closely correlated with 
consumption level. Patients relied more on the imported drugs for their medications than on 
the domestic brands. This study therefore did not consider physicians as the respondents rather 
it utilizes patients, leaving a gap on how brand image can influence prescription behaviour 
among physicians in the hospitals. 
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Moreover, Corrao et al., (2014) researched on the similarity between generic and brand 
name anti-hypertensive drugs for primary prevention of cardiovascular disease. The study was 
a population based and had a sample size of 2206 anti-hypertensive patients. After analysis 
using logistic regression to model CV risk associated with either generic or brand name, it was 
established that there was a weak support on the notion that brand name anti-hypertensive 
medicines are superior to generics for preventing CV outcomes in the real world clinical 
practice. This study employed a methodology that is not familiar by many researchers. In 
addition, the study did not consider influence of brand image among physicians, rather it 
involve brand image among patients. This study sought to bridge this gap. 
There has been a growing trend in prescription of medicines over the years depending on the 
drug classes (McCarthy, 2013). A study by Barbui and Conti (2014) on the adherence to generic 
or the brand antidepressant (AD) treatment and the key role of health system factors established 
that the use of generic brand image was associated with improved adherence and also the lower 
cost associated with it. The study involved 16,778 Medicare fee-for-service beneficiaries who 
received a new depression diagnosis and initiated generic versus brand name AD therapy. This 
study further focused on patients and not the physicians who prescribe drugs. As such, there 
was need to fill the gap. 
2.3.2 Brand Commitment and Prescription Behaviour 
Long term success of any organization depends on its ability to create long term relationship 
with its clients. Commitment is very effective in the organization (Eisingerich & Rubera, 
2010). Building strong perception require physicians to have brand commitment towards the 
brand and the pharmaceutical. There is increased competition in the market where firms are 
offering similar products and services. With this in mind, management must design their brand 
in a way that align with their physicians’ preferences so as to increase their level of brand 
commitment (Kimpakorn & Tocquer, 2010). Since that most studies have not brought out 
relationship between brand commitment and prescription behaviour, especially in areas where 
rate of anti-hypertensive is high, this study bridged the gap through determining how brand 
commitment may influence prescription behaviour of the physicians in this environment. 
Therefore, brand commitment can be explained as an enduring desire to keep a valued 
relationship (Choi & Ahluwalia, 2013).It can be affective or continuance. Affective 
commitment is the extent to which consumers want to keep the relationship based on their 
emotional attachment to the brand while continuance commitment results when the benefits of 
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the relationship is much more than the cost associated with the brand. The findings of Ramirez, 
Vloutsou and Morgan-Thomas (2017) indicated that the presence of brand commitment is 
necessary for a successful process of building loyalty which detect spurious behaviours and 
habits seen in some medical organizations. However, there was limited evidence of these study 
findings in the developing nations where anti-hypertensive challenges are high. This therefore 
provided a gap that needed to be filled especially in understanding how brand commitment 
influence prescription behaviour. 
In assessing the relationship between brand commitments, brand credibility, perceived quality, 
customer satisfaction and brand loyalty, Javed, Aslam, Khan and Bibi (2014) established that 
group advertisement can help build brands, but dependability is what makes them preceding. 
This is because if consumers believe they share values with an organization, they will remain 
loyal to a particular brand. As such, the study sampled 200 female consumers with self-
administered questionnaire. The findings of the study demonstrated that brand commitment is 
effective in enhancing brand loyalty, so do other variables of the study. This study was 
undertaken on consumers especially women, and therefore did not established the prescription 
behaviour of physicians; medical doctors and clinicians. The study therefore aimed to bridge 
the gap.  
According to a research by Turi, Smith and Kemp (2013) brand relationships can provide 
consumers with resources in making decisions, meeting their needs, and motivating them. Their 
study explored developing affective brand commitment through social media in the context of 
personal branding. The study findings illustrated that emotional relationships are cultivated by 
the intimacy and self-connection the consumer has towards the brand. Therefore, the intimacy 
or connection can result to emotional attachment or bond of consumer behaviours towards their 
actions. However, there are limited evidence to support their findings in relation to prescription 
behaviour among doctors and clinicians, especially in areas perceived to have increased anti-
hypertensive intake. 
2.3.3 Brand Experience and Prescription Behaviour 
Brand experience is a type of experimental selling or marketing technique that includes a 
holistic set of terms or conditions created by the management to influence consumer’s 
(physician’s) feelings towards their brand or brand image. A study by Biedenbach and Marell 
(2010) on the impact of customer experience and brand equity in business to business services 
setting established that there is need for creating a positive customer experience through a 
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direct interaction of customers (physicians) with the company and its brand. This study was 
not undertaken in the field of healthcare management. As a result, there exist a gap that the 
study sought to bridge and demonstrate influence of brand experience on prescription 
behaviour of doctors and clinicians. 
Healthcare organizations use brand experience as a strategy aimed at helping them convert 
brand awareness to brand loyalty (Verhoef, Lemon, Parasuraman, Roggeveen, Tsiros & 
Schlesinger, 2009). After exploring the effects of brand awareness on consumer purchase 
intentions with perceived quality and brand loyalty as mediating variables, Chi, Yeh, & Yang 
(2009) found out that there is a significant positive correlation between brand awareness, 
perceived quality and brand loyalty and consumer purchase intention and this could extend to 
the prescription behaviour of physicians in the health organizations. This study involved 
consumers as the main respondents and did not sought to include the opinion of doctors and 
clinicians as the prescribers of medicines in the hospitals. As such, this study sought to bridge 
the gap and provide empirical evidence on how brand experience influence prescription 
behaviour among physicians in perceived anti-hypertensive areas. 
Francisco-Maffezzolli et al., (2014) analysed creating loyalty through brand experience with 
mediating role of brand relationship quality. A survey based quantitative approach of 306 
respondents at consumers of perfume and bath soaps was used to test the hypothesis. The study 
found out that there was no direct impact between brand experience and brand loyalty for either 
category of the products while there exists a positive relationship between brand experience 
and brand relationship quality. This study was not carried out on physicians as it only focused 
on consumers of perfume and bathing soaps. Leaving a gap that need to be filled in relation to 
how brand experience may influence prescription behaviour among physicians in the hospitals. 
2.4 Research Gap 
Given the development in healthcare management on how medical officers prescribe drugs to 
their patients, and also the increased anti-hypertensive medicine intakes in the country more so 
in Kiambu (Mutual et al., 2014), there is need to understand how brand loyalty influence the 
prescription behaviour of anti-hypertensive medicine by doctors and clinicians in Kiambu 
Level 4 and  Ruiru Sub-County Hospitals. The recent publications on anti-hypertensive 
medicines and treatment only address it from the prevalence point of view with less focus on 
the influence of brand loyalty by medical officers on its prescription (Gatwiri, 2017; Meme, 
2017; Benjamin et al., 2017; Ataklte et al., 2014). 
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Moreover, a review on the concept of brand loyalty with its predictors (brand image, brand 
commitment and brand experience) have focused more on satisfaction in other sectors and not 
health organizations (Turi, Smith & Kemp, 2013; Verhoef, Lemon, Parasuraman, Roggeveen, 
Tsiros & Schlesinger, 2009; Eisingerich & Rubera, 2010), with few studies such as (Moerman, 
2006; Li, Cai, Zhang, Fei & Xu, 2017; Corrao et al., 2014) attempting to address the influence 
of brand image in the pharmaceutical industry but from the patient perspectives. 
The prescription behaviour of medical and clinical officers more so in prescription of anti-
hypertensive medicines is becoming very important for the health care management strategists. 
Many studies as aforementioned therefore do not explain the influence that brand loyalty has 
on prescription behaviour of physicians, more so in the Kenyan context. To bridge this gap and 
understand the prescription behaviour of physicians, there was need to investigate brand loyalty 
and its influence on prescription behaviour of anti-hypertensive medicines by medical officers 
and clinical officers in Kiambu Level 5 and Ruiru Sub-County Hospitals. 
2.5 Conceptual Framework 
This is a model which demonstrate the existing relationship between brand loyalty (brand 
image, brand commitment and brand experience) and prescription behaviour of anti-




















Source: Author (2019) 
Figure 2.1 Conceptual Framework 
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2.6 Operationalization of Variables 
Operationalization is the concept of simplifying variables into a simple terms that can be easily 
understood by different individuals interested in the study. It enhances the measurability of 
research variables so as to answer research questions. Likert scale of 1 – 5 was used to measure 
the research variables since the study seeks to obtain primary data. 
Table 2.1 Operationalization of Variables 
Variables  Indicators  Rating scale measure Empirical review 
Brand image  Brand name and 
origin 
 Brand memorability 
 Brand differentiation 









Cai et al., 2017 
Corrao et al., 2014 
McCarthy, 2013 
Barbui& Conti, 2014 
Brand 
commitment 
 Brand preference 













Eisingerich & Robera, 
2010 
Kimpakorn & Tocquer, 
2010 
Choi & Ahluwahi, 2013 
Ramirez, Vloutsou & 
Morgan-Thomas, 2017 
Javed, Aslam, Khan & 
Bibi, 2014 
Turi, Smith & Kemp, 2013  
Brand experience   Awareness 
 Association 
 Expectations 
 Reputation  







Biedenbach & Marell, 
2010 
Verhoef et al., 2009 






 Cost of drugs 
 Individual issues 
 Drug issues 







Sharifinia et al., 2018 
Nair, Manchanda & 
Bhatia, 2010 
Kenneth, Lukhawata & 
Chandra, 2016 
 






Methodology provides a plan and procedure of getting information to achieve research 
objectives. It outlines research design, target population, data collection technique, research 
quality, diagnostic tests, data analysis and presentations and ethical considerations. 
3.2 Research Design 
Research design refers to the techniques and methods that the researcher followed in obtaining 
data (Mackey & Gass, 2015; Brown, 2006). This study was a descriptive research study. 
According to Hakim (2012), descriptive studies involves observing and describing the 
behaviour or characteristics of a subject, population or events of the study without influencing 
them in any way. Also, Saunders, Lewis and Thornhill (2012) explained that this type of 
research is usually conducted to gather the general view of the subject under the study.  
3.3 Target Population 
Population refers to the total number of elements, objects or persons under consideration for 
the study and have similar traits (Wahyuni, 2012). The target population for the study were 
both medical officers and clinical officers in the hospitals. The reason for this population for 
the study was because they are the people who interact with patients on a daily basis and 
understand the rate of intake of anti-hypertensive drugs in the hospital. 
Inclusion exclusion criteria for the study was 3 months. Only those who have been in the 
hospital more than 3 months were included in the study since they may have knowledge of 
anti-hypertensive intake and their level of prescriptions. Based on the human resource (HR) 
data in the hospitals, there were 21 medical officers and 34 clinical officers in the health 
facilities combined. For this reason, the target population of the study was 55 respondents. A 
census survey therefore was taken on the study respondents. 
Table 3.1 Target Population 







Total  55 100 
Source: Human Resource Data (2019) 
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3.4 Data Collection Method 
Data collection methods refers to the ways the study used to obtain data needed for the analysis 
(Bellamy, 2011). Since that the study was primary type, structured questionnaires were used. 
According to Bellamy (2011), questionnaires are considered good data collection methods 
since they are useful in gaining first-hand information and storing information till further notice 
for use in making study inferences. Questionnaire was also useful in collecting quantitative 
information as it also emphasized on the anonymity of the respondents.  
3.5 Data Collection Procedure 
The researcher visited the research site and sought permission from the relevant body within 
the institutions to obtain data from the target respondents, with explanation of the purpose and 
the significance of the study to them (Creswell &Poth, 2017). Once given the authority to 
proceed with reaching out to the target respondents, the researcher personally administered the 
questionnaires since the population was manageable without involving so much cost in getting 
help from the research assistant. The questionnaire was used for obtaining quantitative data for 
the analysis. The questionnaires were self-administered to the respondents through a drop and 
picked method. This entailed that the researcher dropped the questionnaires for the respondents 
to fill and later picked them for data analysis. 
3.6 Research Quality 
Research quality refers to the level of accuracy and consistency of the research instruments in 
measuring the research objectives. 
3.6.1 Reliability of the Study 
Refers to the extent to which the research instrument may produce consistent results over time. 
The reliability of the study was determined by Cronbach’s alpha test where values of 0.7 and 
above implied that the instrument was reliable enough for giving consistent results while values 
below 0.7 meant that the research instrument was not reliable enough to give consistent results 
(Hyett, Kenny & Dickson-Swift, 2014). The study established that all the variables had alpha 
value of above 0.7 which indicates that the instrument can provide a reliable study findings 




Table 3.2 Reliability Results 
Cronbach’s alpha Reliability Test Results 
Variables Alpha Items 
Brand image 
Brand commitment  










Sources: Research Data (2019) 
3.6.2 Validity of the Study 
Validity refers to the extent to which the data collection instrument truly measures what it ought 
to measure by providing accurate results. This was done by assessment of the specific questions 
in the questionnaire so as to determine whether they were effective and accurate enough to give 
appropriate information aimed at answering the research questions by the supervisor (Taylor, 
Bogdan, & DeVault, 2015). The information given was used to improve the questionnaire 
questions so as to make them easy and simple for respondents to understand. 
3.7 Data Analysis and Presentation 
Data analysis refers to techniques used to simplify the research findings through coding, editing 
and encoding them for easy understanding in making study conclusion. Quantitative 
techniques, descriptive and inferential statistics were applied. Descriptive statistics involved 
use of mean and standard deviation to present the findings. Inferential statistics involved use 
of regression analysis and correlation analysis to determine the association between study 
variables. Also, statistical package of social sciences (SPSS) was used to develop the multiple 
regression model as follows; 
𝛾 = 𝛽0 + 𝛽1𝑋1 + 𝛽2𝑋2 + 𝛽3𝑋3 + 𝜀 
Where; 
𝛾 = 𝑃𝑟𝑒𝑠𝑐𝑟𝑖𝑝𝑡𝑖𝑜𝑛 𝑜𝑓 𝐴𝑛𝑡𝑖 − 𝐻𝑦𝑝𝑒𝑟𝑡𝑒𝑛𝑠𝑖𝑣𝑒 𝐷𝑟𝑢𝑔𝑠 
𝛽0 − 𝛽3 = 𝑅𝑒𝑔𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠 
𝑋1 = 𝐵𝑟𝑎𝑛𝑑 𝑖𝑚𝑎𝑔𝑒 
𝑋2 = 𝐵𝑟𝑎𝑛𝑑 𝑐𝑜𝑚𝑚𝑖𝑡𝑚𝑒𝑛𝑡 
𝑋3 = 𝐵𝑟𝑎𝑛𝑑 𝑒𝑥𝑝𝑒𝑟𝑖𝑒𝑛𝑐𝑒 
𝜀 = 𝑒𝑟𝑟𝑜𝑟 𝑡𝑒𝑟𝑚 
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3.7.1 Diagnostic Tests 
This section assumes that data was gathered from the normally distributed population. It 
therefore suggest that before choosing the appropriate model of the study or conducting the 
regression analysis. Tests such as normality and linearity were performed (Bellamy, 2011). 
a) Normality test 
Was determined to assess if the data for the study was normally distributed or not, where a p-
value more than 0.05 showed that data was normally distributed (Null hypothesis, H0) and a p-
value of less than 0.05 showed that data was not significantly distributed (Alternative 
hypothesis, H1).(Creswell & Poth, 2017). 
b) Linearity test 
This test was performed using Pearson’s correlation coefficient to show the relationship 
between the study variables. It established the strength of the relationship whether it was 
negative or positive. A positive relationship implied direct impact while a negative meant weak 
or no impact (Hakim, 2012). 
3.8 Ethical Considerations 
Ethics refers to doing things in accordance with the stipulated rules and guidelines set. For this 
study to uphold the ethical standards of both the institutions of higher learning body and the 
organization chosen for the study, it first obtained a stamped introductory letter from the 
university and then National Commission for Science, Technology and Innovation 
(NACOSTI) research permit from the Ministry of Education. Thereafter, the researcher 
proceeded to the field of the study and seek for permission from the management of the 
organization before meeting the target respondents for the study. Lastly, the researcher stated 
categorically that the purpose of the study is for education and all information gathered were 





DATA ANALYSIS AND PRESENTATION OF THE FINDINGS 
4.1 Introduction 
This section of the study provides findings of the study based on analysis of the information 
gathered. Quantitative analysis, descriptive statistics and inferential statistics are used to 
provide information for making study conclusions. The section therefore has demographic 
factors, descriptive and inferential statistics. 
55 questionnaires as a data collection tool were sent to the respondents by the researcher. Only 
33 were duly filled and returned for analysis. This represented a 60% response rate. 
Table 4.1 Response Rate 
Category  Frequency Percentage 
Filled  





Total  55 100 
Source: Research Data (2019) 
4.2 Demographic Information 
This section describes the general information of the respondents in relation to their age, 
education and years of service. 
4.2.1 Age 
This section sought to establish the age of the respondents and the findings were presented in 
table 4.2  
Table 4.2 Age 
Age  Frequency Percentage 
20 – 25 years 
26 – 30 years 
31 – 35 years 









Total  33 100 
Source: Research Data (2019) 
The study established that 40% of the respondents were in the age bracket of 20 – 25 years, 
30% were in 26 – 30 years, 12% in 31 – 35 years while 18% were above 35 years. This implied 
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that majority of the respondents were in the prime age believed to be easily influenced by 
external factors hence the need to undertake the study as presented in table 4.2 
4.2.2 Education 
Results of the study revealed that 48% of the respondents had diploma, 22% undergraduate, 
30% graduate while no respondent had postgraduate studies. The findings therefore meant that 
there was an even distribution of education in the hospitals. 
Table 4.3 Education 












Total  33 100 
Source: Research Data (2019) 
4.2.3 Years of Service 
In estimating the years of service of the respondents, the study found out that 48% of the 
respondents had less than 1 year, 22% had 1 – 3 years, 12% had 4 – 6 years and 18% had above 
6 years. The implication of this finding is that it enables the study to understand the level of 
experience that the respondents has towards understanding their prescription behaviour and 
how brand loyalty may play a role in it. 
Table 4.4 Years of Service 
Years of Service Frequency Percentage 
Less than 1 year 
1 – 3 years 
4 – 6 years 









Total  33 100 
Source: Research Data (2019) 
4.3 Diagnostic Test 
This test was determined to estimate the fitness of the model for the study. Only if the model 
meets the test recommendations than multiple regression model can be used to estimate 
relationship of the study variables. 
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4.3.1 Normality Test 
Was performed to establish whether the residual data was normally distributed or not, for it to 
be used in the study. Based on the residual of the variables, the study established that the study 
had a skewness of .0581 and kurtosis of .2413 with a p-value of .0862 which is higher than a p 
– value .05. An indication that the data was normally distributed and significant for the study. 
This therefore implied that data for the study was sufficient for running descriptive and 
inferential analysis. 
Table 4.5 Skewness/Kurtosis Test for Normality 
Normality Test Results 
Obs Pr (skewness) Pr (kurtosis) Adj chi2 (2) Pro>chi 
33 .0581 .2413 4.16 .0862 
Source: Research Data (2019) 
4.4 Descriptive Statistics  
This section provides the results on the influence of brand image, brand commitment and brand 
experience on prescription of anti-hypertensive behaviour among medical and clinical officers 
at Kiambu level 5 and Ruiru sub-county hospitals. The study used mean and standard 
deviations. 
4.4.1 Brand Image 
The first objective of the study was to determine influence of brand image on prescription of 
anti-hypertensive behaviour of medical officers and the findings were as follows. 
The study findings in table 4.6 indicated that patient’s ability to remember/recall (memory) 
these medicines in the hospital affects my prescribing decision with a mean of 3.6061. This 
therefore translates that the ability of patients in remembering the previous ant-hypertensive 
drugs they have used before sticks in their mind and as a result, creates an image that they 
would want to consume over time. Such behaviours forces physicians in most cases to prescribe 
drugs based on patient’s demand and ability to recall. Therefore, the study findings found that 
a high mean of 3.0 suggest that respondents agreed that brand image is important in explaining 




Table 4.6 Brand Image 
Statement  Mean Std. Dev 
I prescribe these drugs based on the personality behind it 
I provide patients with information regarding brand name and origin 
when seeking for treatments 
Patient’s ability to remember/recall (memory) theses medicines in the 
hospital affects my prescribing decision 
I prescribe these medicines based on the positive experience you had 
with it and not the patient 
Brand differences is very essential during my prescribing decision 




















Overall mean 3.8939  
Source: Research Data (2019) 
4.4.2 Extent of Brand Image 
The study sought to assess whether brand image have influence on prescribing behaviour of 
anti-hypertensive drugs among medical officers in the hospitals. The findings indicated that 
64% of the respondents said yes while 36% said no. The findings therefore may imply that 
majority of the respondents understand that in some instances, they prescribe drugs based on 
their image in the hospital. 
Table 4.7 Extent of Brand Image 







33 33 100 
Source: Research Data (2019) 
 4.4.3 Brand Commitment  
The second objective of the study was to analyse the influence of brand commitment on 




Table 4.8 Brand Commitment 
Statement  Mean Std. Dev. 
My attitudes and loyalty determines how I prescribe these medicines over 
time 
At times I prescribe these medicine based on my preferential motive 
My character as a clinician makes me prescribe these medicines the way I 
want 
I prescribe these medicines based on their brand acceptability in the market 
Emotional connection of patients towards these medicines determines my 
prescribing behaviour 
My relationship with drug suppliers determines my prescribing behaviour 





















Overall mean 2.3838  
Source: Research Data (2019) 
The study findings showed that I prescribe these medicines based on their acceptability in the 
market had a mean of 3.2121. The level of acceptability of anti-hypertensive drugs among 
patients may be a sign that patients themselves have high level of commitment on consuming 
the drugs. And as a result, making physicians to have a predetermined behaviour in prescribing 
these drugs.  In addition, the emotional relationship that patients and physicians at times have 
may also enhance physicians’ level of commitment hence prescribing anti-hypertensive drugs 
based on the commitment towards the drugs. 
4.4.4 Extent of Brand Commitment 
The study also determined the extent of brand commitment on prescribing behaviour of medical 
officers.  
Table 4.9 Extent of Influence of Brand Commitment 
Extent of Influence Frequency Percentage 
Great extent  
Moderate extent  
Little extent  









Total  33 100 
Source: Research Data (2019) 
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Results showed that 12% said great extent, 36% moderate extent, 30% little extent while 22% 
no extent. The findings demonstrated that there was an even distribution on the extent of 
influence of brand commitment on prescription as established by the study. 
4.4.5 Brand Experience  
The study also established how brand experience may influence prescription behaviour among 
clinicians on anti-hypertensive drugs.  
Table 4.10 Brand Experience  
Statement  Mean Std. Dev 
I prescribe anti-hypertensive drug based on the drug awareness in the 
market 
My level of association with the pharmaceutical firms determines my 
prescribing behaviour 
Patients insist on getting anti-hypertensive drugs with good reputation 
irrespective of the available alternative medicines serving the same 
purpose 
The feedback I get from your patients in some cases determines how 
my next prescription decision will be. 
Also, consumer attitudes is a major factor since some of them insist 






















Overall mean 3.0788  
Source: Research Data (2019) 
From the study findings in table 4.10, the feedback I get from your patients in some cases 
determines how my next prescription decision will be with a mean of 3.9697 while I prescribe 
anti-hypertensive drug based on the drug awareness in the market had a mean of 3.4242. These 
findings therefore illustrates that the experience physicians have with anti-hypertensive drugs 
determines how they prescribe drugs to the patients in the hospital.  
4.4.6 Patient’s Insistence 
The study also investigated whether the patient’s insistence on a particular anti-hypertensive 
drug affect medical officer’s prescribing behaviour. 64% said yes while 36% said no. The 
implication of this finding therefore is that doctors and clinicians in some cases may give in to 
the demands of the patients (consumers) of anti-hypertensive drugs in the hospital.  
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Table 4.11 Patient’s Insistence 







Total  33 100 
Source: Research Data (2019) 
4.4.7 Prescription Behaviour of Anti-Hypertensive Drugs  
Prescription behaviour of anti-hypertensive drugs in the two hospitals were performed.  
Table 4.12 Prescription Behaviour of Anti-Hypertensive Drugs 
Statement  Mean Std. Dev 
I consider cost of these drugs at the time of prescribing decision 
I take into account drug issues such as side effects and their characteristics 
during prescribing decision. 
I also identify individual issues such as patient’s drug preference during 
prescribing decision making 
Various forms of marketing promotion by pharmaceutical firms may 














Overall mean 3.6365  
Source: Research Data  
The findings in table 4.12 revealed that I take into account drug issues such as side effects and 
their characteristics during prescribing decision with a mean of 4.4545. In addition, I consider 
cost of these drugs at the time of prescribing decision had a mean of 4.0606. Many patients do 
not have the ability to purchase high cost medicines and as a result, rely of cost effective 
medicines. Physicians therefore consider cost of these drugs and their side effects when 
performing their prescriptions. 
4.4.8 Facility as a Determinant 
The study further sought the opinion of the respondents to indicate whether facility 
(public/private) determines how they prescribe drugs for their patients. 78% said yes while 
22% said no. This implied that good hospitals and structures may determine how physicians 
prescribe these medicines as compared to other hospitals with poor structures and lack of 
enough skilled doctors. 
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Table 4.13 Facility as a Determinant 







Total  33 100 
Source: Research Data (2019) 
4.5 Inferential Statistics 
The section presents findings on correlation and regression analysis of the study. 
4.5.1 Correlation Analysis 
Correlation analysis was performed to determine the correlation between study variables.  
Table 4.14 Pearson Correlation Matrix Results 















































































*Correlation is significant at the .01 level (2-tailed) 
*Correlation is significant at the .05 level (2-tailed) 
Source: Research Data (2019) 
There was a weak positive correlation between brand experience and prescription of anti-
hypertensive behaviour among medical officers (r = .3950, p < .05). Further, brand image and 
brand commitment had a weak positive correlation with prescription behaviour with a 
correlation coefficients of .3070 and .2108 respectively. However, their significance level was 
above .05 level of significance. The positive correlation coefficient results therefore implied 
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that both brand image, brand commitment and brand experience correlates positively with 
prescription behaviour among doctors and clinicians in the hospitals. 
4.5.2 Regression Analysis 
This analysis was used to fit the data into the fitted model where R2 was used as a measure of 
explaining the variations in prescription behaviour of medical officers as a result of changes in 
brand image, brand commitment and brand experience. 
The F statistics in analysis of variance (ANOVA) was used to measure goodness of fit of the 
model. 
Further, regression coefficient summary was determined to explain the established relationship 
between independent variables (brand image, brand commitment and brand experience) and 
dependent variables (prescription of anti-hypertensive behaviour) of the study. 
Table 4.15 Model Summary  
Model  R R - Square Adjusted R - Square Std. Error of the Estimate 
1 .4341a .1884 .1044 .7033 
a. Predictors: (Constant), Brand image, Brand commitment, Brand experience 
Source: Research Data (2019) 
The coefficient of determination (R2) of the model was estimated at .1884 indicating that 
18.84% of prescription of anti-hypertensive behaviour among physicians was influenced by 
brand image, brand commitment and brand experience. This therefore implied that the 
remaining percentage are explained by other variables which were excluded from the model. 
R of .4341 shows that there is a positive correlation between the study variables. 
Table 4.16 ANOVA Results 
ANOVA 














a. Predictors: (Constant), Brand image, Brand commitment, Brand experience 
b. Dependent Variable: Prescription of Anti-hypertensive Behaviour 
Source: Research Data (2019) 
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The findings of the ANOVA for regression coefficient reveals that there was a significant 
relationship between brand image, brand commitment, brand experience and prescription of 
anti-hypertensive behaviour among medical officers with F value of 2.24 as shown in the table 
below. 
The study also sought to determine the relationship between brand image, brand commitment 
and brand experience and prescription behaviour among physicians. The findings established 
an intercept of 2.0864 on the constant variable which indicates that if all the three predictors 
(brand image, brand commitment and brand experience) were held constant, then prescription 
behaviour would be 2.0864. 
Table 4.17 Regression Coefficients 





1  B Std. Error Beta t Sig. 
(Constant) 























a. Dependent Variable: Prescription behaviour of anti-hypertensive drugs 
Source: Research Data (2019) 
The regression model equation therefore was; 
𝛾 = 2.0864 + 0.2533𝑋1 − 0.0227𝑋2 + 0.3232𝑋3 + 𝜀 
The brand image (X1) and brand experience (X3) had a beta coefficient value of .2533 and 
.3232 respectively indicating that a unit increase in both of them would result to a unit increase 
in prescription behaviour among doctors and clinicians by 25.33% and 32.32% respectively. 
The positive relationship therefore implied that both brand image and brand experience have 
positive influence on prescription behaviour among doctors and clinicians in the hospitals. 
However, a unit increase in brand commitment (X2) will result to a decrease of 2.27% of 
prescription behaviour of anti-hypertensive drugs. The results on the relationship between 
brand commitment and prescription behaviour therefore implied that there was a negative 
relationship between the two variables of the study. 
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However, the p-values of the three independent variables of the study (brand image, .292; brand 
commitment, .899 and brand experience, .100) were all above 0.05 level of significance 
suggesting that their influence on prescription behaviour among medical doctors and clinicians 





SUMMARY, DISCUSSION, CONCLUSION AND RECOMMENDATIONS 
5.1 Introduction 
The chapter presents discussion, conclusion and recommendations of the study. It also 
discusses research summary based on the research objectives, methodologies used and 
descriptive findings. The chapter therefore encompasses summary, discussion, conclusion, and 
recommendation, areas of further study and limitation of the study. 
5.2 Summary  
The objective of the research was to find out the influence of brand loyalty on prescription 
behaviour of anti-hypertensive drugs among physicians in Kiambu level 5 and Ruiru Sub-
County Hospitals. The specific objectives were; to determine the influence of brand image, 
brand commitment and brand experience on prescription behaviour of anti-hypertensive drugs 
among physicians. 
This study adopted descriptive research design using quantitative approach. The study 
populace was drawn from two hospitals; Kiambu level 5 and Ruiru sub-county hospitals. A 
census survey was taken on 55 medical and clinical officers in the two hospitals. Findings 
established that majority of the respondents took part in the study. Moreover, majority of the 
respondents were in the age bracket of 26 – 30 years and also in the diploma level of education. 
A normality test performed on data for the study revealed that data was normally distributed 
and significant for making study inferences. The study findings further revealed that there was 
a weak positive correlation between study variables (brand image, brand commitment and 
brand experience) with prescription behaviour of physicians on anti-hypertensive drugs. Only 
brand image and brand experience had a positive relationship with prescription behaviour of 
anti-hypertensive drugs with brand commitment having negative relationship. 
5.3 Discussion 
This chapter presents the discussion of the study results based on the research objectives. It 
compares the findings and scholarly reviews on the literature review of the study. 
5.3.1 Influence of Brand Image 
Majority of the respondents indicated that brand image has influence on prescription behaviour 
of anti-hypertensive drugs among physicians in the hospitals. A regression analysis established 
that brand image had an insignificant positive relationship with physicians’ prescription 
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behaviour of anti-hypertensive drugs in the hospital. This finding correlated with the findings 
of Barbui and Conti (2014) whose study established that generic image of medicines was 
associated with improved adherence and lower cost of it. As such, brand image creates a long-
lasting picture in the minds of the physicians, hence influencing how they prescribe these 
medicines in the hospital. 
Further, the study also indicated a weak positive correlation between brand image and 
prescription behaviour of anti-hypertensive drugs. This finding was supported by Corrao et al., 
(2014) who pointed out that there exist weak support on the notion that brand name anti-
hypertensive medicines are superior to generics hence does not critically explain the concept 
of physicians’ prescription behaviour. This could as a result of brand name not having effective 
positive results into the minds of the patients rather than in the minds of the physicians. The 
study also found out that ability of the patients to remember or recall anti-hypertensive 
medicines in the hospital affects physician’s prescribing behaviour. 
Moerman (2006) addressed brand image and prescription behaviour of physicians on utilization 
of various drugs in the hospitals by the patients. The study’s findings is in line with this research 
that brand image has influence on prescription behaviour of anti-hypertensive drugs. A drug 
with a brand name that is easy to recall and is affordable by many in the market can lead to 
high utilization capacity. When this occur, the influence of brand names increases in the market 
hence influencing how prescribe them to the patients. Further, the study established that 
medical and clinical officers provide patients with information regarding medicine’s brand 
name and its origin when seeking for treatment. Giving enough information regarding the drug 
to the patients enables them to have a positive attitudes towards drugs through prescription 
behaviour of the physicians in the hospital and these influence how they will prescribe these 
medicines in the future. 
5.3.2 Influence of Brand Commitment 
The results of the study further revealed that there was a negative relationship between brand 
commitment and prescription behaviour of anti-hypertensive drugs among medical and clinical 
officers in both hospitals. The findings illustrate that brand commitment such as emotional 
relationships and intimacy that physicians put on drugs in most cases do not influence their 
prescription behaviour, especially in regards to prescription of anti-hypertensive drugs. The 
study findings disagreed with the previous study by Turi, Smith and Kemp (2013) who found 
out that emotional relationships cultivated by the intimacy and self-connection that physicians 
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has towards the medicine brand and the company determines how they prescribe drugs in the 
hospital. As a result, commitment level varies may not have positive influence on prescription 
behaviour of physicians in regards to anti-hypertensive drugs. 
The study also found that that brand commitment had a weak positive correlation with 
prescription behaviour of anti-hypertensive drugs by medical and clinical officers. In line to 
this, the study also indicated that physicians prescribe anti-hypertensive drugs based on their 
brand acceptability in the market as their awareness and the information that patients has on 
them. This was supported by the previous study brand commitment and brand loyalty by Javed, 
Aslam, Khan and Bibi (2014) who found out that brand commitment is effective in enhancing 
brand loyalty which may influence the prescription behaviour level of physicians towards anti-
hypertensive drugs in the hospitals. However, with a p-value higher the recommended level of 
significance, the influence of brand commitment therefore cannot be significant in influencing 
the prescription behaviour of anti-hypertensive drugs by physicians in both hospitals. 
Even though the study found a negative relationship between brand commitment and 
prescription behaviour of anti-hypertensive drugs among physicians, Ramirez, Vloutsou and 
Morgan-Thomas (2017) disagreed with this study findings. Their results established that 
presence of brand commitment is necessary for a successful process of building loyalty which 
in most cases determines how physicians prescribes their drugs in the hospitals. The mixed 
results could be attributed to different purpose of the study. This study focused on prescription 
behaviour of anti-hypertensive drugs by physicians while the latter study was on general 




5.3.3 Influence of Brand Experience 
The study found a positive relationship between brand experience and prescription behaviour 
of anti-hypertensive drugs among physicians in the hospitals. This was very significant on 
explaining why interaction of physicians with the medicine is key at explaining their 
prescription behaviour in the hospital. Further, the study revealed that the feedback that the 
physicians get from their patients enhance their level of experience which in some cases, 
determines their next prescription behaviour. This finding concurred with the study findings of 
Fransisco-Maffellozzi et al., (2014) who also found out that there is a direct relationship 
between brand experience and relationship quality which describes the prescription behaviour 
of physicians in the hospital. When physicians have experience, they can be able to detect 
original and counterfeit drugs in the market, hence determining their prescription behaviour of 
anti-hypertensive drugs in the hospital. 
The study also revealed that there was a positive correlation between bran experience and 
prescription behaviour of anti-hypertensive drugs among medical and clinical officers in the 
hospitals. This was as a result that in most cases, patient’s insistence on certain prescription of 
anti-hypertensives drugs by physicians enhance prescribers’ experience which makes them 
know each patient in the hospital and their preferred medicines at some stage. The findings 
explained the earlier findings of Chi, Yeh and Yang (2009) that there is significant positive 
correlation between brand awareness, perceived quality and prescription intentions of the 
physicians in the hospital. 
A study by Biedenbach and Marell (2010) also agreed with this study results that there is need 
for creating a positive customer experience through a direct interaction of physicians and their 
patients as well as between physicians and pharmaceutical companies. Pharmaceutical firms 
rely mostly on the experience that physicians have towards prescribing anti-hypertensive drugs 
since that having enough knowledge is an added advantage that physicians should have to aid 
in detecting genuine drugs in the market. The study further revealed that patient’s insistence 
on certain anti-hypertensive drugs coupled with a continuous attitude enhances their behaviour 





The study utilized brand image, brand commitment and brand experience as the study 
independent variables. Of these three variables, the study concluded that both brand image and 
brand experience had insignificant positive relationship with prescription behaviour of anti-
hypertensive drugs among physicians. However, they positively influences prescription 
behaviour of the physicians. The study also concluded that there was no relationship between 
brand commitment and prescription behaviour of anti-hypertensive drugs by physicians in the 
hospitals. As a result, the study further concluded that physician’s prescription behaviour of 
anti-hypertensive drugs is essential due to a growing hypertensive intake rate in the country 
especially in Kiambu County. 
Moreover, the study also concluded that interactions that physicians have in the hospital 
through frequent description of anti-hypertensive drugs can enhance their experience level, by 
detecting original and genuine drugs from the counterfeit ones. This creates high level of 
precaution in prescription of various medicines and as result enhancing their level of brand 
experience. The study further concluded that brand and image experience as a type of brand 
loyalty influences prescription behaviour not only on anti-hypertensive drugs but also other 
drugs in the hospital leading to efficient utilization of health services across various health 
facilities.  
5.5 Recommendations 
The study recommends that hospitals, especially where the rate of hypertension intake is high 
need to examine how components of brand loyalty such as brand image, brand commitment 
and brand experience may influence prescription behaviour of these drugs by their physicians. 
To the pharmaceutical companies, image should not only be aimed to influence physicians to 
prescribe drugs but should portray a clear goals and objectives of the company in the eyes of 
the physicians and their patients. 
Patients consume drugs more when they feel motivated with the results they get after utilization 
drugs such as anti-hypertensive ones. Medical and clinical officers therefore should not just 
prescribe medicines to clear stock rather on the experience that that the prescribed drugs may 
solve illness challenges of the patients. The study therefore recommends that physicians need 
to control their behaviour by upholding the medical integrity to avoid been influenced by 
temporary factors such as the image rather than what the medicine can treat in the long-run. 
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5.6 Areas of Further Study 
There should be a further study on extent of influence of brand loyalty on prescription 
behaviour of anti-hypertensive drugs among physicians in other hospitals since the rate of 
hypertension intake is slightly spreading to other areas in Kenya, not only in Kiambu. Also, 
there is need to establish whether these variables used in the study (brand image, brand 
commitment and brand experience) are the only brand loyalty variables influencing 
prescription behaviour of anti-hypertensive drugs among medical and clinical officers in 
various hospitals.  
5.7 Limitations of the Study 
The study was limited to only two hospitals which are Kiambu level 5 and Ruiru sub-county 
hospitals and did not involve other hospitals in Kiambu County or in Kenya. Only three 
independent variables were utilized in achieving the research objective; brand image, brand 
commitment and brand experience. In addition, the study only targeted physicians’ mainly 
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Appendix 2: Questionnaire 
You are kindly requested to take part in this study by filling in the questionnaire. Also, 
information given should be appropriate and accurate enough to ease in making study 
conclusions. All information given will be treated with utmost confidentiality and is for 
academic purposes only. Please do not include your name. Tick where appropriate (√) 
SECTION A: BACKGROUND INFORMATION 
1. Age 
20–25 years  [ ] 26 – 30 years  [ ] 
31 – 35 years  [ ] above 35 years [ ] 
2. Education level 
Diploma   [ ] Undergraduate [ ] 
Graduate  [ ] Post Graduate  [ ] 
3. Years of service 
Less than 1 year  [ ] 1 – 3 years  [ ] 
4 – 6 years  [ ] above 6 years  [ ] 
SECTION B: BRAND IMAGE 
4. The following statements are descriptive of brand image in relation to anti-hypertensive 
drug. Please indicate with a tick(√)your level of agreement with each statement in a scale of 
1-5 where 1=strongly disagree (SD), 2=agree (A), 3=not sure (N), 4=agree (A) and 5=strongly 
agree (SA). 
 Statement  SD D N A SA 
1 I prescribe these drugs based on the personality behind it      
2 I provide patients with information regarding brand name and origin 
when seeking for treatments 
     
3 Patient’s ability to remember/recall (memory) theses medicines in the 
hospital affects my prescribing decision 
     
4 I prescribe these medicines based on the positive experience you had 
with it and not the patient 
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5 Brand differences is very essential during my prescribing decision      
6 Patients order me to prescribe these drugs for them based on the colour 
and texture 
     
6. Does brand image have impact on prescribing behaviour of anti-hypertensive drugs? 
Yes   [ ]  No  [ ] 
SECTION C: BRAND COMMITMENT 
7. The following statements are descriptive of brand commitment in relation to anti-
hypertensive drugs. Please indicate with a tick (√)your level of agreement with each statement 
in a scale of 1-5 where 1=strongly disagree (SD), 2=agree (A), 3=not sure (N), 4=agree (A) 
and 5=strongly agree (SA). 
 Statement  SD D N A SA 
1 My attitudes and loyalty determines how I prescribe these medicines 
over time 
     
2 At times I prescribe these medicine based on my preferential motive      
3 My character as a clinician makes me prescribe these medicines the way 
I want 
     
4 I prescribe these medicines based on their brand acceptability in the 
market 
     
5 Emotional connection of patients towards these medicines determines 
my prescribing behaviour 
     
6 my relationship with drug suppliers determines my prescribing 
behaviour in the hospital 
     
8. To what extent does brand commitment influence my prescribing behaviour? 
Great extent  [ ]  Moderate extent  [ ] 
Little extent  [ ]  No extent   [ ] 
SECTION D: BRAND EXPERIENCE 
9. The following statements are descriptive of brand experience in relation to anti-hypertensive 
drugs. Please indicate with a tick (√)your level of agreement with each statement in a scale of 




 Statement  SD D N A SA 
1 I prescribe anti-hypertensive drug based on the drug awareness in the 
market 
     
2 My level of association with the pharmaceutical firms determines my 
prescribing behaviour 
     
3 Patients insist on getting anti-hypertensive drugs with good reputation 
irrespective of the available alternative medicines serving the same 
purpose 
     
4 The feedback I get from your patients in some cases determines how 
my next prescription decision will be. 
     
5 Also, consumer attitudes is a major factor since some of them insist 
only on the specific drugs that they want 
     
10. Does the patient’s insistence on a particular anti-hypertensive dug affect my prescribing 
behaviour? 
Yes   [ ]  No  [ ] 
SECTION E: PRESCRIPTION BEHAVIOUR OF MEDICAL AND CLINICAL 
OFFICERS IN REGARDS TO ANTI-HYPERTENSIVE DRUGS. 
11. The following statements are descriptive of prescription behaviour of medical and clinical 
officers in regards to anti-hypertensive drugs. Please indicate with a tick (√)your level of 
agreement with each statement in a scale of 1-5 where 1=strongly disagree (SD), 2=agree (A), 
3=not sure (N), 4=agree (A) and 5=strongly agree (SA). 
 Statement  SD D N A SA 
1 I consider cost of these drugs at the time of prescribing decision      
2 I take into account drug issues such as side effects and their 
characteristics during prescribing decision. 
     
3 I also identify individual issues such as patient’s drug preference during 
prescribing decision making 
     
4 Various forms of marketing promotion by pharmaceutical firms may 
persuade how I prescribe drugs for patients 
     
12. Does facility (public or private) determines how I prescribe drugs for my patients? 




Appendix 3: Consent form 
Study Title: Brand Loyalty and Its influence on Prescription behaviour by Medical Officers and 
Clinical Officers in Kiambu level 5 and Ruiru Sub-County Hospitals 
Foreword: to you study Participant 
Investigator: MUHUNI JAMES NJOROGE   (Master of Business Administration in Healthcare 
Management) STRATHMORE BUSINESS SCHOOL, STRATHMORE UNIVERSITY. 
Contact Telephone Number(s): 0711859864 Email: nmuhuni@gmail.com 
Purpose of study: The study aim to investigate Brand Loyalty and Its influence on Prescription 
behaviour by Medical Officers and Clinical Officers in Kiambu level 5 and Ruiru Sub-County Hospitals 
 How to Participate: You will be asked to give responses and your opinion to some questions which 
will be asked regarding the medication administration process ~taking approx 10-15mins. 
 Right to refusal or withdrawal: Taking part in this study is your choice; you may choose not to be in 
it. Your participation is voluntary and you are free to agree or disagree to participate in this study. You 
may withdraw from the study at any time even after signing this form and there will be no victimization. 
Confidentiality and privacy: Your involvement in this research study will be kept confidential by 
identifying you in the study records by a code/unique number. The study results/report that will be used 
in final the publication (thesis) will not use your name. 
Risks and benefits: There are no risks or discomforts associated with this study and neither are there 
any direct benefits to you for taking part in. 
For further clarifications or questions on this study, please contact me 
Investigator: James Muhuni (Mobile: 0711859864) Email nmuhuni@gmail.com OR 
My Supervisor: Dr. Nancy Njiraini (Mobile: 0727071100: Email: nnjiraini@strathmore.edu OR  
Enquiries to:   The Secretary- Strathmore University Institutional Ethics Review Board, 
 P.O BOX 59857-00200, NAIROBI; Email: ethicsreview@strathmore.edu; Tel No: + 254 703 034 375 
Your signature indicates that this research study has been explained to you, that you’ve been 
given the opportunity to ask questions, and that you agree to take part in this study.  
Signature: ….................................................             Date: .......................................................                                                             
For Official Use: 
Name:……………………  Signature:…………………….  Date: ……………………… 






























Appendix 8: Budget 
This is the proposed budget plan for the project study 
Items Cost in KES 
Stationery 23,000 
Typing and internet services 6,000 
Printing and binding  1,800 
Proof-reading and editing   2,200 
Miscellaneous cost 3,000 
Data analysis 55,000 
Total  96,000 
 
